Co-Authors
This is a "connection" page, showing publications co-authored by Sophie Trouillet-Assant and Karen Brengel-Pesce.
Connection Strength
1.047
-
Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 Oct 04; 218(10).
Score: 0.241
-
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 10 04; 218(10).
Score: 0.240
-
Type-I Interferon assessment in 45 minutes using the FilmArray® PCR platform in SARS-CoV-2 and other viral infections. Eur J Immunol. 2021 04; 51(4):989-994.
Score: 0.232
-
Type I IFN immunoprofiling in COVID-19 patients. J Allergy Clin Immunol. 2020 Jul; 146(1):206-208.e2.
Score: 0.220
-
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study. Sci Rep. 2021 07 22; 11(1):14977.
Score: 0.060
-
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del). Clin Microbiol Infect. 2020 07; 26(7):960-962.
Score: 0.055